Agios Pharmaceuticals
AGIO
AGIO
159 hedge funds and large institutions have $1.62B invested in Agios Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 71 increasing their positions, 49 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
5% less funds holding
Funds holding: 168 → 159 (-9)
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
Holders
159
Holding in Top 10
–
Calls
$16.5M
Puts
$10.4M
Top Buyers
| 1 | +$23.2M | |
| 2 | +$15.3M | |
| 3 | +$14.9M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.82M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.85M |
Top Sellers
| 1 | -$9.98M | |
| 2 | -$8.53M | |
| 3 | -$7.68M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.48M |
| 5 |
Goldman Sachs
New York
|
-$5.54M |